Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by ...

Novo Nordisk is cutting the price of its weight-loss ... The injectable medication's price is the same for five dosages ranging from 0.25 to 2.4 milligrams and will be shipped directly to ...